Immunogenicity and protection conferred by a recombinant Mycobacterium marinum vaccine against Buruli ulcer

Bryan E. Hart, Laura P. Hale, Sunhee Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Mycobacterium ulcerans (MU) infection causes the disfiguring necrotic skin disease, Buruli ulcer (BU). While vaccination with Mycobacterium bovis BCG provides nominal antigenic cross-reactivity for induction of immunity against experimental MU infection, a mycobacterial species with greater genetic homology to Mycobacterium ulcerans may serve as a richer source of cross-protective immunogens and lack the pathological features of MU-based vaccines. Mycobacterium marinum, a highly homologous genetic relative of MU, could be used to satisfy these criteria and, as such, we have generated a recombinant M. marinum strain expressing the immunodominant, protective MU-Ag85A. The immunogenicity and protection achieved by murine vaccination with this strain are superior to standard BCG vaccination and may serve as a foundation for developing more effective BU vaccines.

Original languageEnglish (US)
Pages (from-to)88-91
Number of pages4
JournalTrials in Vaccinology
Volume5
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Mycobacterium ulcerans
Buruli Ulcer
Mycobacterium marinum
Vaccines
Mycobacterium bovis
Vaccination
Skin Diseases
Immunity

Keywords

  • Ag85A
  • Buruli ulcer
  • M. marinum
  • Mycobacterium ulcerans
  • Vaccine

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Immunogenicity and protection conferred by a recombinant Mycobacterium marinum vaccine against Buruli ulcer. / Hart, Bryan E.; Hale, Laura P.; Lee, Sunhee.

In: Trials in Vaccinology, Vol. 5, 01.01.2016, p. 88-91.

Research output: Contribution to journalArticle

@article{55cbf52af2184e23b3a83e8eda829ca7,
title = "Immunogenicity and protection conferred by a recombinant Mycobacterium marinum vaccine against Buruli ulcer",
abstract = "Mycobacterium ulcerans (MU) infection causes the disfiguring necrotic skin disease, Buruli ulcer (BU). While vaccination with Mycobacterium bovis BCG provides nominal antigenic cross-reactivity for induction of immunity against experimental MU infection, a mycobacterial species with greater genetic homology to Mycobacterium ulcerans may serve as a richer source of cross-protective immunogens and lack the pathological features of MU-based vaccines. Mycobacterium marinum, a highly homologous genetic relative of MU, could be used to satisfy these criteria and, as such, we have generated a recombinant M. marinum strain expressing the immunodominant, protective MU-Ag85A. The immunogenicity and protection achieved by murine vaccination with this strain are superior to standard BCG vaccination and may serve as a foundation for developing more effective BU vaccines.",
keywords = "Ag85A, Buruli ulcer, M. marinum, Mycobacterium ulcerans, Vaccine",
author = "Hart, {Bryan E.} and Hale, {Laura P.} and Sunhee Lee",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.trivac.2016.04.001",
language = "English (US)",
volume = "5",
pages = "88--91",
journal = "Trials in Vaccinology",
issn = "1879-4378",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Immunogenicity and protection conferred by a recombinant Mycobacterium marinum vaccine against Buruli ulcer

AU - Hart, Bryan E.

AU - Hale, Laura P.

AU - Lee, Sunhee

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Mycobacterium ulcerans (MU) infection causes the disfiguring necrotic skin disease, Buruli ulcer (BU). While vaccination with Mycobacterium bovis BCG provides nominal antigenic cross-reactivity for induction of immunity against experimental MU infection, a mycobacterial species with greater genetic homology to Mycobacterium ulcerans may serve as a richer source of cross-protective immunogens and lack the pathological features of MU-based vaccines. Mycobacterium marinum, a highly homologous genetic relative of MU, could be used to satisfy these criteria and, as such, we have generated a recombinant M. marinum strain expressing the immunodominant, protective MU-Ag85A. The immunogenicity and protection achieved by murine vaccination with this strain are superior to standard BCG vaccination and may serve as a foundation for developing more effective BU vaccines.

AB - Mycobacterium ulcerans (MU) infection causes the disfiguring necrotic skin disease, Buruli ulcer (BU). While vaccination with Mycobacterium bovis BCG provides nominal antigenic cross-reactivity for induction of immunity against experimental MU infection, a mycobacterial species with greater genetic homology to Mycobacterium ulcerans may serve as a richer source of cross-protective immunogens and lack the pathological features of MU-based vaccines. Mycobacterium marinum, a highly homologous genetic relative of MU, could be used to satisfy these criteria and, as such, we have generated a recombinant M. marinum strain expressing the immunodominant, protective MU-Ag85A. The immunogenicity and protection achieved by murine vaccination with this strain are superior to standard BCG vaccination and may serve as a foundation for developing more effective BU vaccines.

KW - Ag85A

KW - Buruli ulcer

KW - M. marinum

KW - Mycobacterium ulcerans

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84964622027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964622027&partnerID=8YFLogxK

U2 - 10.1016/j.trivac.2016.04.001

DO - 10.1016/j.trivac.2016.04.001

M3 - Article

VL - 5

SP - 88

EP - 91

JO - Trials in Vaccinology

JF - Trials in Vaccinology

SN - 1879-4378

ER -